Mankind Pharma Limited
Mankind Pharma Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: MANKIND and BSE: 543904 (ISIN INE634S01028).
It has a market capitalisation of ₹93,012 crore, a last close of ₹2,253 on 2026-10-19, a one-year return of -9.0%.
Valuation: a price-to-earnings ratio of 45.53x, a price-to-book ratio of 5.71x, a dividend yield of 0.0%.
Profitability: return on equity of 12.5%, return on capital employed of 13.6%, an operating margin of 26.0%.
Growth: sales growth of 17.7% a year over three years, net profit growth of 14.3% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.39x, promoter holding of 72.6%.
| Metric | Value |
|---|---|
| Market capitalisation | 93,012 |
| Last close | ₹2,253 |
| P/E (TTM) | 45.53x |
| P/B | 5.71x |
| Dividend yield | 0.0% |
| ROE (FY) | 12.5% |
| ROCE (FY) | 13.6% |
| Operating margin (TTM) | 26.0% |
| Sales growth, 3-year CAGR | 17.7% |
| Profit growth, 3-year CAGR | 14.3% |
| Debt / equity | 0.39x |
| Promoter holding | 72.6% |
| 1-year return | -9.0% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means